Commonwealth Bank of Australia’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-1,100
Closed -$47K 92
2019
Q2
$47K Sell
1,100
-1,200
-52% -$51.3K ﹤0.01% 985
2019
Q1
$98K Hold
2,300
﹤0.01% 932
2018
Q4
$103K Sell
2,300
-2,200
-49% -$115K ﹤0.01% 921
2018
Q3
$308K Buy
+4,500
New +$290K ﹤0.01% 816
2015
Q2
Sell
-812
Closed -$40K 773
2015
Q1
$40K Sell
812
-531
-40% -$24.6K ﹤0.01% 729
2014
Q4
$61K Buy
+1,343
New +$52.8K ﹤0.01% 653

Other funds holding AVNS

Commonwealth Bank of Australia's AVNS Position: Q3 2019 in Review

Commonwealth Bank of Australia sold out of Avanos Medical (AVNS) in Q3 2019, closing a stake of 1,100 shares — an estimated $47K sold.

Commonwealth Bank of Australia first reported a position in AVNS in Q4 2014 and held it in 6 quarters. The position peaked at $308K in Q3 2018. 290 funds tracked by Wall St. Rank hold AVNS as of Q3 2019.

  • Commonwealth Bank of Australia reported no remaining Avanos Medical position as of Q3 2019 after selling out during the quarter.
  • Commonwealth Bank of Australia sold 1,100 Avanos Medical shares in Q3 2019, an estimated $47K.
  • Commonwealth Bank of Australia first reported a position in Avanos Medical in Q4 2014 and held it in 6 quarters.
  • Commonwealth Bank of Australia's Avanos Medical position peaked at $308K in Q3 2018.
  • 290 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2019.

Based on Commonwealth Bank of Australia's 13F filing for Q3 2019.